Nobuo Mochizuki

TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · The Lancet Oncology · 2017 · 175 citations

Medicine, Oncology, Pharmacology +9

Phase I trial of <scp>GBS</scp>‐01 for advanced pancreatic cancer refractory to gemcitabine

Masafumi Ikeda, Akihiro Sato, Nobuo Mochizuki et al. · Cancer Science · 2016 · 58 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study

Kaho Miura, Yoshiyuki Sano, Seiji Niho et al. · Thoracic Cancer · 2021 · 49 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Distribution of micafungin in the tissue fluids of patients with invasive fungal infections

Noriaki Yamada, Keisuke Kumada, Shinji Ogura et al. · Journal of Infection and Chemotherapy · 2011 · 41 citations

Life Sciences, Microbiology, Pharmacokinetics +14

Antifungal Activity of Micafungin in Serum

Jun Ishikawa, Tetsuo Maeda, Itaru Matsumura et al. · Antimicrobial Agents and Chemotherapy · 2009 · 20 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17